Cipla stock trades at INR 1,301.00, 22.2 percent below its 52-week high

Published on 10/09/2026 at 15:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cipla's next results are scheduled for October 27, 2026. Cipla stock stood at INR 1,301.00 on October 9, 2026, versus INR 1,306.80.

Key points in brief

Cipla stock stood at INR 1,301.00 on October 9, 2026, down 0.44 percent from INR 1,306.80.
The price was 22.24 percent below the INR 1,673.00 52-week high and 11.61 percent above the INR 1,165.70 low.
Market capitalization was INR 1.1 trillion and the P/E ratio was 31.20 as of October 9, 2026.
Cipla is scheduled to report its next results on October 27, 2026.

Cipla, INE059A01026, Illustration mit AI erstellt.

Cipla (INE059A01026) was trading at INR 1,301.00 on the NSE on October 9, 2026 at 3:15 p.m. IST, down 0.44 percent from INR 1,306.80. NSE lists October 27, 2026 as the date for Cipla's next financial results.

Price stays below the yearly high

The latest INR 1,301.00 price was 22.24 percent below the 52-week high of INR 1,673.00 and 11.61 percent above the 52-week low of INR 1,165.70. Both range points were dated October 9, 2026, while the current quote carried a minus 0.44 percent daily change against the prior close.

The stock's year-to-date performance was minus 12.93 percent as of October 8, 2026, compared with minus 14.97 percent for the NIFTY 50 on the same NSE market page. The comparison places Cipla ahead of the benchmark by 2.04 percentage points over that period.

Valuation and analyst expectations

Cipla's market capitalization was INR 1.1 trillion on October 9, 2026, with a P/E ratio of 31.20 and a dividend yield of 0.01 percent. Trading volume was 653,431 shares, compared with an average volume of 1,020,701 shares.

Investing.com listed an average 12-month analyst target of INR 1,512.83 and 36 analyst ratings. At INR 1,301.00, that target was 16.28 percent above the latest quote, a comparison that keeps valuation in view without changing the stock's current market position.

Comparison with peers

Cipla: minus 0.44 percent, P/E 31.20, market capitalization INR 1.1 trillion
Sun Pharmaceutical Industries (NSE, INR): plus 0.01 percent, P/E 34.91, market capitalization INR 4.2 trillion
Dr. Reddy's Laboratories (NSE, INR): plus 1.44 percent, P/E 30.14, market capitalization INR 997.1 billion

Results date sets the next marker

The October 27, 2026 results date is the next scheduled company event. The price report therefore turns on the gap to Cipla's yearly high, the year-to-date comparison with the NIFTY 50 and the valuation spread against comparable Indian drugmakers.